Abstract P1-08-05: The mechanism of FOXO3a in coping with oxidative stress to promote TNBC progression

Abstract Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer associated with poor prognosis and limited treatment options. FOXO3a is an important transcription factor participating in many important biological process. It has been reported that FOXO3a expression is associated with lymph node metastasis and poor disease-free survival in TNBC. We also found that overexpression of FOXO3a in MDA-MB-231 cells could promote lung metastasis of by tail vein injection in vivo. However, the mechanism of FOXO3a in TNBC progression remains unclear. Here, we found that FOXO3a was highly expressed in nuclear of TNBC tissues than that in peritumor tissues by immunohistochemistry staining. FOXO3a enhances the invasion and motility of TNBC cells by transwell assays. RNA-sequencing combined bioinformatic analysis suggest that FOXO3a is closely related to adhesion pathway and PI3K/AKT pathway. Considering FOXO3a could translocate to nuclear to activate downstream signaling pathway under oxidative stress. Therefore, we further showed that FOXO3a could activate FAK/PI3K/AKT pathway under oxidative stress to promote TNBC progression. Collectively, our research showed that the expression of nucleus FOXO3a was related to the progression of TNBC, and FAK/PI3K/AKT pathway participate in the role of FOXO3a in promoting the progression of TNBC. FOXO3a may serve as a prognostic biomarker and a potential therapeutic target for TNBC. Citation Format: Manqing Cao. The mechanism of FOXO3a in coping with oxidative stress to promote TNBC progression [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2024; 2024 Dec 10-13; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(12 Suppl):Abstract nr P1-08-05.

Authors

Publication Details

Journal
Clinical Cancer Research
Published
2025-06-13
DOI
https://doi.org/10.1158/1557-3265.sabcs24-p1-08-05
Primary Topic
FOXO transcription factor regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract P1-08-05: The mechanism of FOXO3a in coping with oxidative stress to promote TNBC progression

Manqing Cao
Clinical Cancer Research
FOXO transcription factor regulation
article

Abstract P1-08-05: The mechanism of FOXO3a in coping with oxidative stress to promote TNBC progression

Manqing Cao
article en

Abstract

Abstract Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer associated with poor prognosis and limited treatment options. FOXO3a is an important transcription factor participating in many important biological process. It has been reported that FOXO3a expression is associated with lymph node metastasis and poor disease-free survival in TNBC. We also found that overexpression of FOXO3a in MDA-MB-231 cells could promote lung metastasis of by tail vein injection in vivo. However, the mechanism of FOXO3a in TNBC progression remains unclear. Here, we found that FOXO3a was highly expressed in nuclear of TNBC tissues than that in peritumor tissues by immunohistochemistry staining. FOXO3a enhances the invasion and motility of TNBC cells by transwell assays. RNA-sequencing combined bioinformatic analysis suggest that FOXO3a is closely related to adhesion pathway and PI3K/AKT pathway. Considering FOXO3a could translocate to nuclear to activate downstream signaling pathway under oxidative stress. Therefore, we further showed that FOXO3a could activate FAK/PI3K/AKT pathway under oxidative stress to promote TNBC progression. Collectively, our research showed that the expression of nucleus FOXO3a was related to the progression of TNBC, and FAK/PI3K/AKT pathway participate in the role of FOXO3a in promoting the progression of TNBC. FOXO3a may serve as a prognostic biomarker and a potential therapeutic target for TNBC. Citation Format: Manqing Cao. The mechanism of FOXO3a in coping with oxidative stress to promote TNBC progression [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2024; 2024 Dec 10-13; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2025;31(12 Suppl):Abstract nr P1-08-05.

Clinical Cancer ResearchVol. 31(12_Supplement)
Openalex Percentile: Top 88%
FOXO transcription factor regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.